Laura A. Lane
Corporate Officer/Principal en ELI LILLY AND COMPANY .
Perfil
Laura A.
Lane was the founder of Virion Biotherapeutics Ltd.
which was founded in 2015, where she held the title of Chief Operating Officer & Director from 2015 to 2018.
Currently, she is a Vice President at Eli Lilly & Co. since 2022.
Previously, she worked as a Principal at Advent Venture Partners LLP from 2019 to 2022.
Ms. Lane received her undergraduate and doctorate degrees from the University of Cambridge.
Cargos activos de Laura A. Lane
Empresas | Cargo | Inicio |
---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/08/2022 |
Antiguos cargos conocidos de Laura A. Lane.
Empresas | Cargo | Fin |
---|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Analista de Capital Privado | 01/10/2021 |
Virion Biotherapeutics Ltd.
Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Fundador | 30/06/2018 |
Formación de Laura A. Lane.
University of Cambridge | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Empresas privadas | 2 |
---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Virion Biotherapeutics Ltd.
Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Laura A. Lane